Comparison of SARS-CoV-2 Delta Versus Omicron Variant and Its Impact on Immunocompromised Versus Immunocompetent Population
COVID · 30.06.2026 · 6 (7) · 111
DOI: 10.3390/covid6070111 ↗Kurz gefasst
Fachartikel in der Zeitschrift COVID, online erschienen am 30.06.2026. Verfasst von Sadia Z. Shah und 15 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The Omicron variant of SARS-CoV-2 is associated with milder symptoms and lower hospitalization and mortality rates than Delta variants, although the impact of Omicron on immunocompromised patients, especially solid organ transplant (SOT) recipients, is still unclear. This study compares the hospitalization rate and outcomes between immunocompromised, immunocompetent, and SOT patients during the Delta and Omicron periods. We included adult patients who tested positive for SARS-CoV-2 on PCR or nasopharyngeal antigen test between 26 June 2021 to 8 September 2022, at our institution. A total of 12,401 COVID-19 patients were included, of which 11,055 were immunocompetent, and 1346 were immunocompromised (375 SOT recipients). Throughout the Delta and Omicron outbreaks, immunocompromised patients exhibited higher comorbidities and 30-day hospitalizations, but rates of mechanical ventilation and ICU-level care were like immunocompetent patients. During the Omicron wave, immunocompromised patients had higher unadjusted relative risk estimates (RR = 2.37, 95% CI 1.96–2.87, p < 0.05) than Delta (RR = 1.58, 95% CI 1.24–2.01, p < 0.05), with higher adjusted relative risk for hospitalization in Omicron (RR = 1.50, 95% CI 1.10–2.03, p = 0.01). Analyses show increased hospitalization risk in immunocompromised during the Omicron wave compared to the Delta wave, with no significant difference in hospitalization outcomes. The relative risk of hospitalization for SOT patients was higher in both waves.
Zitieren
APA
Shah, S. Z., Satashia, P., Isha, S., Johnson, P., Kunze, K., Khan, A. M., Sinclair, J., Attieh, R. M., Bhattacharyya, A., Millian, R. D., Edwards, M. A., Carter, R. E., Spiecher, L., Franco, P. M., Sanghavi, D., & Wadei, H. M. (2026). Comparison of SARS-CoV-2 Delta Versus Omicron Variant and Its Impact on Immunocompromised Versus Immunocompetent Population. COVID, 6(7), 111. https://doi.org/10.3390/covid6070111
Vancouver
Shah SZ, Satashia P, Isha S, Johnson P, Kunze K, Khan AM, et al. Comparison of SARS-CoV-2 Delta Versus Omicron Variant and Its Impact on Immunocompromised Versus Immunocompetent Population. COVID. 2026;6(7):111. doi:10.3390/covid6070111
BibTeX
@article{Shah2026,
author = {Shah, Sadia Z. and Satashia, Parthkumar and Isha, Shahin and Johnson, Patrick and Kunze, Katie and Khan, Abdul Moiz and Sinclair, Jorge and Attieh, Rose Mary and Bhattacharyya, Anirban and Millian, Ricardo Diaz and Edwards, Michael Anthony and Carter, Rickey E. and Spiecher, Leigh and Franco, Pablo Moreno and Sanghavi, Devang and Wadei, Hani M.},
title = {Comparison of SARS-CoV-2 Delta Versus Omicron Variant and Its Impact on Immunocompromised Versus Immunocompetent Population},
journal = {COVID},
year = {2026},
volume = {6},
number = {7},
pages = {111},
doi = {10.3390/covid6070111}
}
EUVIMED